Stem Cell Differentiation and Multiple Myeloma
43 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What do pluripotent stem cells differentiate into?

  • Only proerythroblasts
  • Both myeloid and lymphoid stem cells (correct)
  • Only myeloid stem cells
  • Only lymphoid stem cells
  • Which cytokines are involved in the differentiation of multipotent myeloid stem cells?

  • IL11 and IL6
  • SCF and IL7
  • IL3, GM-CSF, and TPO (correct)
  • IL3 and EPO
  • What is the primary role of SCF in stem cell differentiation?

  • To promote myeloid differentiation exclusively
  • To act as a signaling molecule for lymphoid stem cells only
  • To inhibit differentiation
  • To support the proliferation of stem cells (correct)
  • Which of the following cell types is differentiated from a proerythroblast?

    <p>Basophilic erythroblast</p> Signup and view all the answers

    Which cytokines are important for the differentiation of a lymphoblast?

    <p>IL3 and IL7</p> Signup and view all the answers

    What characterizes multiple myeloma?

    <p>Proliferation of plasma cells</p> Signup and view all the answers

    Which of the following is a common clinical feature indicative of multiple myeloma?

    <p>Lytic bone lesions on X-ray</p> Signup and view all the answers

    What is the median age for diagnosis of multiple myeloma?

    <p>65 years old</p> Signup and view all the answers

    What type of proteins are found in increased concentrations in patients with multiple myeloma?

    <p>Monoclonal proteins</p> Signup and view all the answers

    Which cells are primarily involved in the proliferation seen in multiple myeloma?

    <p>Plasma cells</p> Signup and view all the answers

    What is the life expectancy (OS) typically associated with multiple myeloma?

    <p>Around 5 years</p> Signup and view all the answers

    What is a systemic sign that may suggest multiple myeloma?

    <p>Unexplained anemia</p> Signup and view all the answers

    Which types of cells are primarily involved in the immune response and are mentioned in relation to the characterization of multiple myeloma?

    <p>Plasma cells and B lymphocytes</p> Signup and view all the answers

    What distinguishes multiple myeloma from other plasma cell pathologies?

    <p>Detection of monoclonal protein</p> Signup and view all the answers

    Which of the following is a symptom that may indicate hypercalcemia?

    <p>Drowsiness</p> Signup and view all the answers

    What can result from kidney damage associated with multiple myeloma?

    <p>Acute renal failure</p> Signup and view all the answers

    What is the method used to confirm the presence of M-protein?

    <p>Immunofixation of light chains</p> Signup and view all the answers

    Which stage of the diagnostic process is crucial to avoid negative impacts on multiple myeloma progress?

    <p>Electrophoresis timing</p> Signup and view all the answers

    What does the presence of monoclonal protein (M) in serum or urine indicate?

    <p>A form of monoclonal gammopathy</p> Signup and view all the answers

    Which protein type can be evident in the gamma, beta, or alpha-2 region during electrophoresis?

    <p>Monoclonal protein</p> Signup and view all the answers

    What characterizes protein-M during serum protein electrophoresis?

    <p>Single narrow tip</p> Signup and view all the answers

    What percentage of patients with multiple myeloma (MM) present with anemia at the time of diagnosis?

    <p>73%</p> Signup and view all the answers

    Which symptom is noted to be present in approximately 5% of cases or less in patients with multiple myeloma?

    <p>Paresthesia</p> Signup and view all the answers

    What clinical finding is associated with about 5% of multiple myeloma patients at diagnosis?

    <p>Extramedullary plasmacytoma</p> Signup and view all the answers

    What triggers the bone pain in patients with multiple myeloma?

    <p>Movement</p> Signup and view all the answers

    Which factor is not a predictor for kidney failure recovery in multiple myeloma patients?

    <p>Age of the patient</p> Signup and view all the answers

    What is a common renal damage indicator in multiple myeloma patients at diagnosis?

    <p>Cr &gt; 2 mg/dl</p> Signup and view all the answers

    Which condition is associated with myeloma leptomeningeal involvement?

    <p>Abnormal CSF examination</p> Signup and view all the answers

    What percentage of multiple myeloma patients exhibit increased creatinine levels at diagnosis?

    <p>48%</p> Signup and view all the answers

    What kappa/lambda ratio is indicative of monoclonality in bone marrow?

    <p>4:1 or greater</p> Signup and view all the answers

    Which surface markers are typically expressed by myeloma plasma cells?

    <p>CD79a, CD138, CD38</p> Signup and view all the answers

    According to the Durie-Salmon criteria, which parameter is NOT part of Stage I criteria?

    <p>Beta-2 microglobulin greater than 3.5 mg/l</p> Signup and view all the answers

    Which disease can monoclonal gammopathy be attributed to?

    <p>Metastatic cancer</p> Signup and view all the answers

    What is a characteristic feature of normal plasma cells compared to myeloma plasma cells?

    <p>Expression of CD45</p> Signup and view all the answers

    What is a symptom that should be specifically checked during the clinical examination for multiple myeloma?

    <p>Bone pain</p> Signup and view all the answers

    Which test is NOT a part of the standard investigations for diagnosing multiple myeloma?

    <p>CT scan of the abdomen</p> Signup and view all the answers

    What morphological characteristic is associated with myeloma plasma cells?

    <p>Spoke wheel chromatin</p> Signup and view all the answers

    What type of imaging is particularly useful for evaluating osteolytic lesions in multiple myeloma?

    <p>MRI and PET-CT</p> Signup and view all the answers

    Which of the following tests can indicate the presence of monoclonal proteins in multiple myeloma?

    <p>Serum immunofixation</p> Signup and view all the answers

    Which immune marker detection method is valuable for characterizing myeloma cells?

    <p>Flow cytometry</p> Signup and view all the answers

    Which sign indicates an impending fracture in a multiple myeloma patient?

    <p>Multiple osteolytic lesions</p> Signup and view all the answers

    What term best describes the appearance of cells in multiple myeloma that contain high levels of immunoglobulin?

    <p>Mott cells</p> Signup and view all the answers

    Signup and view all the answers

    Study Notes

    Chronic Lymphoproliferative Disorders II

    • Chronic lymphoproliferative disorders (CLPs) are a group of conditions marked by continuous proliferation of lymphoid cells.

    Lymphocyte Development

    • The provided diagram illustrates lymphocyte development, highlighting various stages and their associated regulatory factors (e.g., IL-3, GM-CSF, SCF).
    • This intricate process shows the differentiation of pluripotent and multipotent stem cells into different types of lymphocytes, including T cells, B cells, and natural killer (NK) cells.
    • Different cytokines play a role at each step of development.

    Monoclonal Gammopathies

    • Monoclonal gammopathies are characterized by the presence of a monoclonal protein (M-protein) in serum or urine.
    • M-protein originates from a single clone of plasma cells, indicative of a proliferative disorder.

    Multiple Myeloma

    • Multiple myeloma (MM) is a rare and incurable neoplasia (cancer).

    • It's characterized by neoplastic plasma cell proliferation, monoclonal immunoglobulin production, bone structure destruction (osteolytic lesions), and frequently-occurring kidney damage.

    • The median age for diagnosis in the EU is 68

    • Approximately 1% of all cancers are multiple myeloma

    • Common presenting features of MM include:

      • Bone pain with lytic lesions (on X-ray)
      • Increased total serum protein concentration
      • Presence of monoclonal protein (M-protein) in urine or serum
      • Systemic symptoms (e.g., anemia, hypercalcemia, acute renal failure)
    • Low life expectancy (OS ~ 5 years)

    • Distinguishing MM from other plasma cell pathologies is vital, as some conditions don't require therapeutic intervention.

    • Timely diagnosis of MM is critical due to its negative impact on disease progression.

    Monoclonal Gammopathies

    • In many cases of monoclonal gammopathies, the presence of M-protein is the key diagnostic criterion.
    • The M-protein is visible as a distinct band on protein electrophoresis, often within the gamma, beta-2, or alpha-2 region.
    • Immunofixation further clarifies the protein's type.
    • In some rare cases, two M-proteins may be detected.

    CLL (Chronic Lymphocytic Leukemia)

    • Chronic Lymphocytic Leukemia (CLL) is characterised by an abnormal increase of B lymphocytes in the blood.
    • CLL is primarily diagnosed between ages 50 and 70 years, often progressing indolently.
    • CLL frequently has features of abnormal white blood cells, but also has distinct markers like B-cells (CD19+ CD5+ ).
    • Key aspects that are important to diagnose CLL include blood lymphocyte analysis and bone marrow analysis including immunophenotyping.
    • This condition involves a malfunction in programmed cell death, leading to the accumulation of abnormal cells.

    CLL Diagnosis and Treatment

    • Peripheral blood with lymphocytosis (>5000/mmc), presence of B lymphocytes with a typical nucleus structure, including smudge cells and abnormalities in bone marrow analysis are important in diagnosis.
    • Different staging systems exist to guide CLL treatment.

    CLL Treatment

    • Indications for CLL treatment depend on the presence and severity of symptoms, as well as specific markers.
    • The presence of B symptoms, advanced-stage disease, rapid progression, and other factors determine the need for treatment.
    • Treatment options include both chemotherapy and targeted therapy.

    CLL Complications

    • Autoimmune hemolytic anemia, infections, and various complications may result from prolonged CLL.
    • Treatment strategies and complications vary considerably, depending on the characteristics of individual cases.

    Treatment Goals in Multiple Myeloma

    • Treatment aims to achieve a balance between short-term treatment response and long-term outcome and quality of life.
    • Continuous regimens are needed to manage the disease effectively without excessive toxicity while preserving quality of life.

    Multiple Myeloma Treatment Options

    • Treatment protocols for MM should consider individual patient profiles to effectively achieve optimal therapeutic outcome.
    • These vary depending on indicators of disease status, and on other patient-related factors, notably age, frailty, and comorbidities.

    Baseline Evaluation

    • Crucial elements of baseline evaluation include assessing both disease-related and patient-related factors—such as performance, status and disease severity. Factors like genetic mutations or circulating plasma cells, or extramedullary disease are important. Further, age, renal function, organ comorbidities, compliance, and patient willingness should be assessed.

    Natural History in Multiple Myeloma

    • Multiple myeloma has stages, from initial diagnosis (NDMM) and symptomatic (MM) and/or smoldering (SMM) disease to different periods of relapse, including early and refractory relapse- and triple/penta-refractory, when other forms of treatment are unsuitable—leading to survival considerations.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz focuses on stem cell differentiation mechanisms, particularly pluripotent and multipotent stem cells. Additionally, it covers the clinical features and characteristics of multiple myeloma, including cytokines involved in the differentiation processes and common signs associated with the condition.

    More Like This

    Stem Cell Differentiation
    60 questions
    Stem Cell Differentiation
    10 questions

    Stem Cell Differentiation

    AttractiveEinstein avatar
    AttractiveEinstein
    Hematopoiesis Stem Cell Differentiation
    40 questions
    Use Quizgecko on...
    Browser
    Browser